Columbia Laboratories, Inc. (Columbia) is engaged in the development and analysis of pharmaceuticals, clinical trial manufacturing of pharmaceutical products for pharmaceutical company customers and the potential development of pharmaceuticals. The Company seeks to research and develop new therapeutic entities utilizing its drug delivery technology for licensing to pharmaceutical companies for commercialization. The Company is focused on the supply of CRINONE to its marketing partner and providing pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry through its wholly owned subsidiary, Molecular Profiles Limited. It has developed and brought to market five bioadhesive vaginal gel products, each commercialized through alliances. All the products developed by the Company utilize its Bioadhesive Delivery System (BDS), which consists of a polymer (polycarbophil) and an active ingredient.